Pharmacology and Drug Metabolism
A section of Metabolites (ISSN 2218-1989).
Section Information
This section of Metabolites is focused on the change in and/or occurrence of small molecule metabolites in in vitro and in vivo systems triggered by drugs and other xenobiotics. This ranges from classic metabolism studied in new compounds to new and emerging tools as well as toxicometabolomics studies, which investigate the fate of the foreign compounds as well as changes in endogenous molecules.
The section “Pharmacology and Drug Metabolism“ in Metabolites is focused on but not limited to:
- Toxicometabolomics (e.g., metabolism of xenobiotics besides answering related metabolomics questions);
- Biomarkers of xenobiotics exposure (e.g., metabolomics to allow for tracing an intake);
- Detailed characterization of xenobiotics metabolism in biofluids and tissues;
- Effect of endogenous microorganisms on biotransformation (e.g., influence of human microbiome on drug metabolism;
- Fate of xenobiotics in wastewater (e.g., impact of microorganisms on survival rate);
- Emerging tools in metabolomics and applied mass spectrometry (e.g., in drug metabolism);
- Drug–drug interactions or drug–food interactions on the metabolism of drugs and, in consequence, on therapeutic management;
- Adverse drug reactions in polypharmacy patients and related management (e.g., PGx-based guiding);
- New developments in toxicokinetics/pharmacokinetics;
- Metabolism and toxicity of compounds released from packaging materials (toxicokinetics and biomonitoring).
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Therapeutic Potentials of Secondary Metabolites from Plants, Microbes and Endophytes (Deadline: 20 June 2023)
- Metabolism of New Psychoactive Substances: Medical, Toxicological and Analytical Aspect (Deadline: 30 June 2023)
- Metabolomics-Driven Drug Discovery and Evaluation (Deadline: 10 July 2023)
- Pharmacology and Toxicology Metabolism of Synthetic and Natural Compounds (Deadline: 10 July 2023)
- Altered Metabolism Associated with Hypertension—a New Option for Drug Therapy? (Deadline: 31 July 2023)
- Design of Novel Target-Oriented Chemotherapeutic Anti-cancer Agents with ADME Pharmacokinetics (Deadline: 31 July 2023)
- Drug Targets Based on Fatty Acid Metabolism (Deadline: 20 September 2023)
- Diabetes, Obesity and Metabolic Disease (Deadline: 30 September 2023)
- Recent Approaches for Scientific Research in Diabetic Nephropathy (Deadline: 24 October 2023)
- Detection, Metabolism and Potential Candidates of Veterinary Medicine and Feedstuff Additives (Deadline: 31 October 2023)
- The Role of Metabolites in Translational and Clinical Pharmacology (Deadline: 15 November 2023)
- Metabolomics in Preclinical Drug Safety Assessment (Deadline: 31 December 2023)